A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Epidemiology

Chemistry

Medicine

Immunology

Show all topics

DOI

10.1101/2022.03.29.486173

License

CC-BY

Other Formats

PDF